Introduction
============

Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is a useful technique to obtain specimens for histopathologic examination. However, there is a small risk of tumor cell seeding along the needle track or within the peritoneum caused by EUS-FNA [@JR820-1] [@JR820-2] . We report needle track seeding following EUS-FNA in a patient with a mediastinal tumor.

Case Report
===========

The patient was a 53-year-old man who presented with hoarseness. Chest computed tomography (CT) revealed a 6-cm mass in the mediastinum ( [Fig. 1](#FI820-1){ref-type="fig"} ). EUS showed a heterogeneous, septated tumor. Transesophageal EUS-FNA was performed (  [Fig. 2a, b](#FI820-2){ref-type="fig"} ). Three passes were made with a 22-gauge needle (Olympus Medical Systems, Tokyo, Japan). During the second pass, necrotic tissue was obtained. No immediate adverse events developed after the EUS-FNA. Pathology showed carcinoma with embryonal features ( [Fig. 2c, d, e](#FI820-2){ref-type="fig"} ).

![ Computed tomography (CT) scan findings. **a** , **b** CT scan revealed a 6-cm mediastinal mass. **c** , **d** Four weeks after endoscopic ultrasound-guided fine-needle aspiration, repeat CT scan revealed a mass in the esophageal wall.](10-1055-s-0043-114662-i820ei1){#FI820-1}

![Endoscopic ultrasound findings and pathologic findings of biopsy specimens. **a** Endoscopic ultrasound showed a tumor with a heterogeneous appearance and a septum. **b** Endoscopic ultrasound-guided fine-needle aspiration was performed with a 22-gauge needle. **c** The biopsy specimen from the tumor showed tumor cells and necrotic tissue. (hematoxylin-eosin, × 4). **d** Tumor cells show a papillary pattern. Nuclei are overlaid and cell polarity is lost. **e** Cells stain positive for AFP ( × 4).](10-1055-s-0043-114662-i820ei2){#FI820-2}

Two weeks after the EUS-FNA, the patient presented with mediastinitis. Symptoms improved with medical therapy. Two weeks later, a repeat CT scan showed a mass in the esophageal wall. Upper gastrointestinal endoscopy showed a protruding lesion in the middle esophagus ( [Fig. 3](#FI820-3){ref-type="fig"} ), which was biopsied using forceps and confirmed to be histologically similar to the mediastinal mass. This was believed to be consistent with needle tract seeding from the EUS-FNA. Tumor resection was not performed because the mass was felt to be technically unresectable, in part due to the tumor seeding. Chemotherapy was administered and the patient died less than 2 years later.

![ Endoscopic findings. **a** Upper gastrointestinal endoscopy showed a mass effect in the middle esophagus. **b** Four weeks after endoscopic ultrasound-guided fine-needle aspiration, a protruding lesion was seen in the middle esophagus](10-1055-s-0043-114662-i820ei3){#FI820-3}

Discussion
----------

This case underscores the potential risk of needle tract seeding after EUS-FNA. In this patient, the location of tumor seeding corresponded to the entry point of the EUS-FNA. The endoscopic unusual appearance of mushroom-shaped tumor protruding from the FNA puncture site was suggestive of seeding as spontaneous direct tumor invasion would be expected to appear as a flat elevation. In addition, the tumor became mucosally based. We believe this is the reason for the rapid development of seeding. The tumor seeding also might have been associated with the post-FNA mediastinitis.

The literature from 2003 to 2016 contains reports on only 14 previous patients with needle tract seeding to gastrointestinal tract wall by a malignancy following EUS-FNA (  [Table 1](#TB820-1){ref-type="table"} ). Needle size, number of passes, needle movement during puncture, suction, and characteristics of the tumor, might be factors in tumor seeding [@JR820-3] . According to previous reports, the number of needle passes and tumor characteristics (poorly differentiated or cystic tumor) are considered to be risk factors [@JR820-2] . Interestingly, needle size was not associated with seeding. In this patient, we speculate that multiple needle passes and tumor characteristics (a poorly differentiated and cystic tumor) may have contributed to development of seeding. Although EUS showed the lesion to be solid, the aspirate showed an abundance of necrotic tissue. We speculated the tumor had a fluid component similar to a cystic tumor.

###### Summary of previous reports of endoscopic ultrasound-guided fine-needle aspiration seeding.

  **No.**   **Author year**   **Aspiration site**                            **Pathological diagnosis**   **Seeding site**                                  **Needle size**   **Passes**   **Interval from EUS-FNA until identification of seeding**
  --------- ----------------- ---------------------------------------------- ---------------------------- ------------------------------------------------- ----------------- ------------ -----------------------------------------------------------
   1        Hirooka, 2003     Pancreatic body mass                           Adenocarcinoma (IPMC)        Posterior gastric wall (and peritoneal seeding)   22G               3            10 days
   2        Shah, 2004        Perigastric lymph node                         Melanoma                     Posterior gastric wall                            22G               1            6 months
   3        Paquin, 2005      Pancreatic tail cancer                         Adenocarcinoma               Posterior gastric wall                            22G               5            16 months
   4        Doi, 2008         Lymph node metastasis of gastric cancer        Adenocarcinoma               Esophageal wall                                   19G               1            18 months
   5        Ashmed, 2011      Cystic mass in the pancreatic body             Adenocarcinoma               Gastric wall of antrum and body                   Unknown           Multiple     4 years
   6        Chong, 2011       Pancreatic tail cancer                         Adenocarcinoma               Posterior gastric wall of body                    22G               2            2 years
   7        Katanuma, 2012    Pancreatic body cancer                         Adenocarcinoma               Posterior gastric wall of upper body              22G               4            22 months
   8        Anderson, 2013    Celiac lymph node (and pancreatic head mass)   Adenocarcinoma               Gastroesophageal junction                         Unknown           Unknown      Unknown
   9        Minaga, 2015      Pancreatic body cancer                         Adenocarcinoma               Posterior gastric wall                            22G               3            8 months
  10        Sakurada, 2015    Pancreatic body cancer                         Adenosquamous carcinoma      Posterior gastric wall                            22G               Unknown      19 months
  11        Tomonari, 2015    Pancreatic body cancer                         Adenocarcinoma               Posterior gastric wall                            22G               2            8 months
  12        Iida, 2016        Pancreatic body cancer                         Adenocarcinoma               Posterior gastric wall                            22G               3            6 months
  13        Kita, 2016        Pancreatic body-tail cancer                    Adenocarcinoma               Posterior gastric wall                            22G               2            7 months
  14        Yamabe, 2016      Pancreatic mass beside cystic lesions          Adenocarcinoma (IPMC)        Posterior gastric wall                            25G               Unknown      3 months
  15        Our Case          Mediastinal tumor                              Embryonal adenocarcinoma     Esophageal wall                                   22G               3            4 weeks

IPMC, intraductal papillary mucinous adenocarcinoma

Peritoneal dissemination has been reported more frequently than needle tract seeding. The exact etiology is unknown but once a patient suffers needle tract seeding, the prognosis is worse.

Conclusion
==========

In conclusion, in patients who have lesions that are surgically resectable for curative intent, we must carefully consider appropriate indications for performing EUS-FNA and inform these individuals about the potential for esophageal seeding, which is rare.

**Competing interests** Dr. Yamamoto has a consultant relationship with FUJIFILM Corporation and has received honoraria, grants and royalties from the company.
